Ducommun
Ducommun's revenue rose 4.9% to $825 million in fiscal 2025. Its operating margin was −4.3%, down from 5.4% a year earlier. Free cash flow was −$49 million, against $20 million a year earlier. The diluted share count fell 0.5%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Ducommun does
Ducommun makes electronic and structural products for aerospace and defense and for industrial customers. It says it offers engineering and manufacturing solutions, from prototype development to complex assemblies.
It has two reportable segments. Electronic Systems designs and makes high-reliability electronic and electromechanical products. Structural Systems designs and makes complex contoured aerostructures and other structures. Its history goes back to a business founded in California in 1849.
Acquisitions are an important part of its growth strategy. In April 2023 it bought BLR Aerospace, a maker of aerodynamic systems for helicopters and airplanes, and added it to Structural Systems.
It also has a production facility in Guaymas, Mexico, and says further consolidation in the aerospace industry could affect it.
Its biggest risks, as it describes them
- Debt that could limit its financing options and its ability to meet its obligations.
- Credit facility covenants that restrict its operating and financial flexibility.
- Depending on a select base of industries and customers.
- Much of its business depends on U.S. government defense spending.
- Tariffs, export controls and supply problems for raw materials and equipment.
Income statement
From fiscal 2016 to 2024, earnings per share fell 5.4% a year and net income 1.9% a year, as new shares raised the share count by 33% and diluted each share's earnings. Ducommun then lost money in fiscal 2025.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 76 | 46 | 43 | 37 | 45 |
| Debt incl. finance leases | 281 | 242 | 258 | 232 | 300 |
| Net debt (negative means net cash) | 205 | 196 | 215 | 195 | 255 |
| Net debt to EBITDA | 2.6x | 2.8x | 3.5x | 2.6x | — |
| Debt to equity | 0.6x | 0.5x | 0.4x | 0.3x | 0.5x |
| Interest coverage | 4.8x | 3.6x | 1.5x | 3.0x | −3.2x |
| Current ratio | 3.0x | 2.6x | 3.0x | 3.2x | 3.5x |
| Quick ratio | 2.1x | 1.8x | 1.9x | 2.1x | 2.5x |
Cash flow
Projections
Project Ducommun's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Ducommun shares on the open market, and 6 insiders sold $7.6 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Stephen G OswaldChairman, President & CEO, Director | Sold | 2,500 | $203.95 | $509,875 | Form 4 |
| Aug 12, 2026 | Stephen G OswaldChairman, President & CEO, Director | Sold | 5,766 | $201.15 | $1.2 million | Form 4 |
| May 28, 2026 | Laureen S. GonzalezV.p., CHRO | Sold | 589 | $151.99 | $89,522 | Form 4 |
| May 20, 2026 | Rajiv A. TataV.p., G.C. & Corp. Secretary | Sold | 1,612 | $145.00 | $233,740 | Form 4 |
| May 20, 2026 | Suman B. MookerjiSr. V.P., C.f.o. | Sold | 1,514 | $145.00 | $219,530 | Form 4 |
| May 14, 2026 | Jerry L RedondoS.v.p., Elec. & Struc. Systems | Sold | 5,682 | $154.36 | $877,074 | Form 4 |
| Mar 10, 2026 | Richard A BaldridgeDirector | Sold | 10,440 | $130.83 | $1.4 million | Form 4 |
| Mar 10, 2026 | Suman B. MookerjiS.v.p., CFO | Sold | 7,791 | $131.90 | $1.0 million | Form 4 |
| Mar 4, 2026 | Suman B. MookerjiSr. V.P., C.f.o. | Sold | 14,709 | $134.21 | $2.0 million | Form 4 |
| Dec 10, 2025 | Jerry L RedondoS.v.p., Elec. & Struc. Systems | Sold | 2,000 | $92.86 | $185,720 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 7 of 9 | 7 of 9 | 5 of 9 |
| Rule of 40 | 7.8% | 6.4% | −1.0% |
| Altman Z'' | 4.92 | 5.42 | 4.71 |
| Accruals ratio | −1.4% | −1.1% | −0.3% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Fail |
| Cash from operations is positive | Pass | Pass | Fail |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Fail | Fail | Pass |
| Gross margin rose | Pass | Pass | Pass |
| Revenue rose relative to assets | Pass | Fail | Pass |
| F-score | 7 of 9 | 7 of 9 | 5 of 9 |
Compare
Put Ducommun side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Ducommun | FY25 | 4.9% | −4.3% | −5.9% | −3.1% | — | 5 | |
| Astronics | FY25 | 8.4% | 8.9% | 5.0% | 16.1% | 3.2x | 7 | Compare |
| VSE | FY25 | 41.5% | 8.1% | 0.5% | 4.5% | 1.7x | 6 | Compare |
| Cadre Holdings | FY25 | 7.5% | 11.0% | 9.3% | 10.4% | 2.2x | 5 | Compare |
| Rocket Lab | FY25 | 38.0% | −38.0% | −53.5% | −30.2% | — | 6 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 551 | 558 | 629 | 721 | 629 | 645 | 712 | 757 | 786 | 825 |
| Revenue growth | −17.3% | 1.4% | 12.7% | 14.6% | −12.8% | 2.6% | 10.4% | 6.2% | 3.9% | 4.9% |
| Gross profit | 106 | 103 | 123 | 152 | 138 | 142 | 144 | 163 | 197 | 222 |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 29 | 16 | 24 | 56 | 46 | 49 | 40 | 29 | 42 | −36 |
| Net income | 25 | 20 | 9 | 32 | 29 | 136 | 29 | 16 | 22 | −37 |
| Diluted EPS (US$) | 2.24 | 1.74 | 0.77 | 2.75 | 2.45 | 11.06 | 2.33 | 1.14 | 1.44 | −2.50 |
| Diluted shares (millions) | 11 | 12 | 12 | 12 | 12 | 12 | 12 | 14 | 15 | 15 |
| Cash flow | ||||||||||
| Cash from operations | 43 | 35 | 46 | 51 | 13 | −1 | 33 | 31 | 34 | −33 |
| Capital expenditure | 17 | 28 | 18 | 18 | 12 | 17 | 20 | 20 | 14 | 15 |
| Free cash flow | 26 | 8 | 29 | 33 | 0 | −17 | 13 | 12 | 20 | −49 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 60 | 0 | 0 | 0 | 0 | 0 | 114 | 0 | 0 |
| Stock-based compensation | 3 | 5 | 5 | 7 | 9 | 11 | 11 | 15 | 27 | 28 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 7 | 2 | 10 | 40 | 56 | 76 | 46 | 43 | 37 | 45 |
| Debt incl. finance leases | 167 | 216 | 229 | 302 | 314 | 281 | 242 | 258 | 232 | 300 |
| Total assets | 515 | 567 | 645 | 790 | 837 | 979 | 1,022 | 1,121 | 1,126 | 1,186 |
| Total liabilities | 303 | 331 | 388 | 498 | 508 | 504 | 496 | 485 | 446 | 525 |
| Shareholders' equity | 212 | 236 | 257 | 293 | 329 | 475 | 526 | 636 | 680 | 662 |
| Margins and ratios | ||||||||||
| Gross margin | 19.4% | 18.5% | 19.5% | 21.1% | 21.9% | 22.1% | 20.2% | 21.6% | 25.1% | 26.9% |
| Operating margin | 5.3% | 2.8% | 3.8% | 7.8% | 7.2% | 7.6% | 5.6% | 3.8% | 5.4% | −4.3% |
| Net margin | 4.6% | 3.6% | 1.4% | 4.5% | 4.6% | 21.0% | 4.0% | 2.1% | 2.8% | −4.5% |
| Free cash flow margin | 4.8% | 1.4% | 4.5% | 4.5% | 0.0% | −2.7% | 1.8% | 1.5% | 2.5% | −5.9% |
| Rule of 40 (growth + FCF margin) | −12.6% | 2.8% | 17.3% | 19.1% | −12.8% | −0.1% | 12.2% | 7.8% | 6.4% | −1.0% |
| Return on capital | 4.9% | 3.8% | 4.5% | 9.4% | 7.3% | 6.1% | 4.9% | 3.6% | 3.9% | −3.1% |
| Return on equity | 12.7% | 9.0% | 3.7% | 11.8% | 9.4% | 33.7% | 5.8% | 2.7% | 3.3% | −5.6% |
| Return on assets | 4.7% | 3.7% | 1.5% | 4.5% | 3.6% | 14.9% | 2.9% | 1.5% | 1.9% | −3.2% |
| Net debt to EBITDA | 3.1x | 5.6x | 4.4x | 3.1x | 3.5x | 2.6x | 2.8x | 3.5x | 2.6x | — |